期刊文献+

他克莫司软膏联合二氧化碳点阵激光治疗白癜风临床观察 被引量:2

The Clinical Observation of Combined Tacrolimus Ointment and CO_2 Fractional Laser for the Treatment of Vitiligo
原文传递
导出
摘要 目的评价外用他克莫司软膏联合二氧化碳点阵激光治疗白癜风临床疗效。方法患者101例,每例患者选择两处相近或对称部位的皮损,随机分为对照组和观察组,对照组皮损仅外用0.1%他克莫司软膏,2次/d,观察组外用他克莫司软膏联合二氧化碳点阵激光治疗,1次/月。治疗观察12周,治疗结束3d后评价疗效。结果对照组与观察组治疗起效时间分别为(6.48±3.13)周和(4.14±3.01)周,组间比较差异有统计学意义(P<0.05)。对照组与观察组总有效率分别为57.42%和79.21%,显效率分别为24.8%和39.6%,组间比较差异均有统计学意义(P<0.05)。所有患者在治疗过程中均未出现严重不良反应。结论他克莫司软膏联合二氧化碳点阵激光治疗白癜风安全有效,疗效优于单用他克莫司软膏。 Objective To evaluate the clinical efficacy of Tacrolimus ointment combined with CO2 fractional laser in the treatment of vitiligo.Methods One hundred and one patients were included,two symmetrical or nearby target lesions of each patients were chosen and were randomly divide into control group and observation group.Both groups of lesions were given Tacrolimus ointment,2 times/day;in addition to that,the treatment group was given CO2 fractional laser,1 times/month.Treatment was observed for 12 weeks,and the efficacy was evaluated after 3 days of treatment.Results The onset time of the control group and the observation group were(6.48 + 3.13) weeks and(4.14 + 3.01)weeks,the difference was statistically significant(P〈0.05).The total effective rate of control group and observation group were 57.42% and 79.2% respectively,and the significant efficiency were 24.8% and 39.6%,the difference was statistically significant(P〈0.05).No serious adverse reactions occurred in all patients during the treatment.Conclusion CO2 fractional laser combined with Tacrolimus Ointment in the treatment of vitiligo is effective and safe,the efficacy is better than the single use Tacrolimus Ointment.
出处 《潍坊医学院学报》 2017年第3期223-225,共3页 Acta Academiae Medicinae Weifang
基金 山东省自然基金联合专项(ZR2013HL068) 潍坊医学院附属医院科技创新基金(K12CX1009)
关键词 他克莫司软膏 白癜风 二氧化碳点阵激光 Tacrolimus Ointment Vitiligo CO2 fractional laser
  • 相关文献

参考文献4

二级参考文献27

  • 1徐荣佳,姚仁南,李晓军,栾建风,武建国.抗人甲状腺过氧化物酶抗体的测定[J].上海医学检验杂志,1996,11(2):68-69. 被引量:2
  • 2Kemp EH, Waterman EA, Gawkrodger DJ, et al. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo[J]. J Invest Dermatol, 1999, 113(2): 267-271.
  • 3van den Boom JG, Konijnenberg D, Dellemijn TA, et al. Au- toimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients[J]. J Invest Dennatol, 2009, 129(9): 2220- 2232.
  • 4腾卫平,曾正陪.中国甲状腺疾病诊治指南[M].北京:人民军医出版社,2009:175-177.
  • 5Halder RM. Childhood vitiligo[J]. Clin Dermatol, 1997, 15(6): 899-906.
  • 6Harm SK, Lee HJ. Segmental vitiligo: clinical findings in 208patients[J]. J Am Acad Dermatol. 1996, 35(5 PI 1): 671-674.
  • 7Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children[J]. Int J Dermatol, 1992, 51(9): 612-623.
  • 8Yang Y, Lin X, Fu W, et al. An approach to the correlation between vitiligo and autnimmune thyroiditis in Chinese ehildren [J]. Clinical Dermatology, 2010, 35(7): 706-710.
  • 9Kroon MW, Joore 1C, Wind BS, et al. Low yield of routine sereening for thyroid dysfunction in asymptomatic patients with vitiligo [J]. Br J Dermatol, 2012, 166(3): 532-538.
  • 10Vanderpump MP, Tunbridge WM, French JM ,et al. The inci- dence of thyroid disorders in the community: a twenty-year fol- low-up of the Whickham survey[J]. Clin Endocrinol, 1995; 43 (1):55-68.

共引文献65

同被引文献18

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部